Tetracycline labeling of the femoral head following acute intracapsular fracture of the femoral neck.

Journal Article

The purpose of this study was to assess the utility of tetracycline hydrochloride (HCl) labeling of the femoral head following acute intracapsular fracture of the femoral neck to indirectly assess femoral head viability and vascularity. A standard labeling (1.5-3.0 g) and fixative protocol (70% ethanol) was used. The initial tetracycline dose was given in the emergency room. The time from last dose to bone sampling in the operating room ranged from six to 36 hours (average, 21.2 hours). There was no evidence of tetracycline deposition at the bone-osteoid interface in any of the femoral head specimens or the ipsilateral extracapsular greater trochanter control specimens. Sources of labeling failure are multifactorial: problems with label delivery to the patient, in vivo deposition of the label, and the fixation protocol.

Full Text

Duke Authors

Cited Authors

  • Speer, KP; Quarles, LD; Harrelson, JM; Nunley, JA

Published Date

  • June 1991

Published In

Start / End Page

  • 224 - 227

PubMed ID

  • 2044284

International Standard Serial Number (ISSN)

  • 0009-921X

Language

  • eng

Conference Location

  • United States